EP3810110A4 - A combination comprising fingolimod and amantadine - Google Patents
A combination comprising fingolimod and amantadine Download PDFInfo
- Publication number
- EP3810110A4 EP3810110A4 EP19823241.5A EP19823241A EP3810110A4 EP 3810110 A4 EP3810110 A4 EP 3810110A4 EP 19823241 A EP19823241 A EP 19823241A EP 3810110 A4 EP3810110 A4 EP 3810110A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- fingolimod
- amantadine
- combination
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TR201808819 | 2018-06-21 | ||
PCT/TR2019/050477 WO2019245513A2 (en) | 2018-06-21 | 2019-06-20 | A combination comprising fingolimod and amantadine |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3810110A2 EP3810110A2 (en) | 2021-04-28 |
EP3810110A4 true EP3810110A4 (en) | 2022-03-16 |
Family
ID=68983747
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP19823241.5A Withdrawn EP3810110A4 (en) | 2018-06-21 | 2019-06-20 | A combination comprising fingolimod and amantadine |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP3810110A4 (en) |
WO (1) | WO2019245513A2 (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013055907A1 (en) * | 2011-10-12 | 2013-04-18 | Teva Pharmaceutical Industries Ltd. | Treatment of multiple sclerosis with combination of laquinimod and fingolimod |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016064997A1 (en) * | 2014-10-22 | 2016-04-28 | The Regents Of The University Of California | Compositions and methods for treating fatigue and depression |
EP3215132B1 (en) * | 2014-11-04 | 2021-01-27 | Adamas Pharmaceuticals, Inc. | Amantadine for improving gait in multiple sclerosis |
-
2019
- 2019-06-20 WO PCT/TR2019/050477 patent/WO2019245513A2/en active Application Filing
- 2019-06-20 EP EP19823241.5A patent/EP3810110A4/en not_active Withdrawn
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013055907A1 (en) * | 2011-10-12 | 2013-04-18 | Teva Pharmaceutical Industries Ltd. | Treatment of multiple sclerosis with combination of laquinimod and fingolimod |
Non-Patent Citations (4)
Title |
---|
ALICE LARONI ET AL: "Safety of the first dose of fingolimod for multiple sclerosis: results of an open-label clinical trial", BMC NEUROLOGY, BIOMED CENTRAL LTD., LONDON, GB, vol. 14, no. 1, 1 April 2014 (2014-04-01), pages 65, XP021184467, ISSN: 1471-2377, DOI: 10.1186/1471-2377-14-65 * |
JEFFREY A COHEN ET AL: "MULTIPLE SCLEROSIS MSJ JOURNAL Safety and efficacy of ADS-5102 (amantadine) extended release capsules to improve walking in multiple sclerosis: A randomized, placebo- controlled, phase 2 trial", 1 January 2018 (2018-01-01), XP055472325, Retrieved from the Internet <URL:http://journals.sagepub.com/doi/pdf/10.1177/1352458518754716> [retrieved on 20180503] * |
LIMMROTH V ET AL: "Electrocardiographic assessments and cardiac events after fingolimod first dose - a comprehensive monitoring study", BMC NEUROLOGY 20170118 BIOMED CENTRAL LTD. GBR, vol. 17, no. 1, 18 January 2017 (2017-01-18), XP009533336, ISSN: 1471-2377 * |
See also references of WO2019245513A2 * |
Also Published As
Publication number | Publication date |
---|---|
EP3810110A2 (en) | 2021-04-28 |
WO2019245513A2 (en) | 2019-12-26 |
WO2019245513A3 (en) | 2020-03-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3626699A4 (en) | Ssao inhibitor | |
EP3537479A4 (en) | Flexible display | |
EP3707537A4 (en) | A field-enhancing device | |
EP3801171A4 (en) | Flat headed mop | |
EP3624885A4 (en) | Positive expiratory pressure device | |
EP3277330A4 (en) | Elastic antimicrobial film and socket made therefrom | |
EP3843216A4 (en) | Low-profile antenna-in-package | |
EP3723651A4 (en) | Medical tools having tension bands | |
EP3847011A4 (en) | A lamitube and implementations thereof | |
EP3954509A4 (en) | Flexible member | |
EP3954510A4 (en) | Flexible member | |
EP3954511A4 (en) | Flexible member | |
EP3713819A4 (en) | A trailer | |
EP3649062A4 (en) | A flexible tank | |
EP3810110A4 (en) | A combination comprising fingolimod and amantadine | |
EP3870768A4 (en) | A clip | |
EP3813533A4 (en) | A functional breadstick | |
EP3882304A4 (en) | Resin sheet | |
EP3649132A4 (en) | A peripherally-restricted dual-actingkappa | |
EP3694380A4 (en) | A device | |
EP3573994A4 (en) | Cysteamine prodrugs | |
EP3565693A4 (en) | Spool with saw wire having elastic and plastic rotations | |
EP3810112A4 (en) | A combination comprising fingolimod and modafinil | |
EP3924012A4 (en) | A clip | |
EP3470614B8 (en) | A cord - blocking element |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20201225 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20220215 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61P 25/00 20060101ALI20220209BHEP Ipc: A61K 31/137 20060101ALI20220209BHEP Ipc: A61K 31/13 20060101AFI20220209BHEP |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20220915 |